Leucodystrophies at children
DOI:
https://doi.org/10.12775/JEHS.2023.44.01.013Keywords
leukodystrophies, hypomyelinating leukodystrophie, Pelizaeus-Merzbacher Disease, dysmyelinating leukodystrophiesAbstract
Introduction
Leukodystrophies involve a diverse group of rare hereditary disorders mostly affecting the white matter of the central nervous system, which straddleses nerves and glial cells. Unfortunately, these conditions are often undervalued by doctors from various specialties. The aim of the article was to present the most common leukodystrophies occurring in children
Material and methods
A review of the most common leukodystrophies based on the available literature. We conducted a systematic literature review. We searched the PubMed and Google Scholar databases from 1997 to 2023.
Conclusions
Leukodystrophies are rare genetic diseases that often present with non-specific symptoms, which can pose diagnostic challenges. Ocular abnormalities and psychomotor delay in the early stages of life should raise suspicion. A combination of symptoms may suggest a pyramidal-extrapyramidal form of cerebral palsy. Therefore, it is crucial to include a head MRI examination in the diagnostic workup and carefully evaluate the findings, as subtle imaging changes can indicate the presence of leukodystrophies. Currently, no causal treatment for leukodystrophies has been developed. Hence, further research is needed to enable the introduction of gene therapies.
References
Ashrafi MR, Amanat M, Garshasbi M, et al. An update on clinical, pathological, diagnostic, and therapeutic perspectives of childhood leukodystrophies. Expert Rev Neurother. 2020;20(1):65-84. doi:10.1080/14737175.2020.1699060. PMID: 31829048.
Charzewska A, Wierzba J, Iżycka-Świeszewska E, et al. Hypomyelinating leukodystrophies - a molecular insight into the white matter pathology. Clin Genet. 2016;90(4):293-304. doi:10.1111/cge.12811. PMID: 27234264.
Singh R, Samanta D. Pelizaeus-Merzbacher Disease. 2022 Jul 4. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32809357.
Osório MJ, Goldman SA. Neurogenetics of Pelizaeus-Merzbacher disease. Handb Clin Neurol. 2018;148:701-722. doi:10.1016/B978-0-444-64076-5.00045-4. PMID: 29478609.
Yan H, Ji H, Kubisiak T, et al. Genetic analysis of 20 patients with hypomyelinating leukodystrophy by trio-based whole-exome sequencing. J Hum Genet. 2021;66(8):761-768. doi:10.1038/s10038-020-00896-5. PMID: 33597727.
Inoue K. Pelizaeus-Merzbacher Disease: Molecular and Cellular Pathologies and Associated Phenotypes. Adv Exp Med Biol. 2019;1190:201-216. doi:10.1007/978-981-32-9636-7_13. PMID: 31760646.
Otero-Dominguez E, Gomez-Lado C, Fuentes-Pita P, et al. Leucodistrofia hipomielinizante de tipo 6. Claves clinicas y de neuroimagen en la deteccion de un nuevo caso [Hypomyelinating leukodystrophy type 6. Clinical and neuroimaging key features in the detection of a new case]. Rev Neurol. 2018;67(9):339-342. Spanish. PMID: 30350845.
Uygun Ö, Gündüz T, Eraksoy M, et al. Adult-onset 4H leukodystrophy: a case presentation and review of the literature. Acta Neurol Belg. 2020;120(6):1461-1462. doi:10.1007/s13760-020-01297-3. PMID: 32052360.
Vanderver A. Genetic Leukoencephalopathies in Adults. Continuum (Minneap Minn). 2016;22(3):916-42. doi:10.1212/CON.0000000000000338. PMID: 27261689.
Gay CT, Hardies LJ, Rauch RA, et al. Magnetic resonance imaging demonstrates incomplete myelination in 18q- syndrome: evidence for myelin basic protein haploinsufficiency. Am J Med Genet. 1997;74(4):422-31. doi:10.1002/(sici)1096-8628(19970725)74:4<422::aid-ajmg14>3.0.co;2-k. PMID: 9259379.
Di Bella D, Magri S, Benzoni C, et al. Hypomyelinating leukodystrophies in adults: Clinical and genetic features. Eur J Neurol. 2021;28(3):934-944. doi:10.1111/ene.14646. PMID: 33190326.
Shaimardanova AA, Chulpanova DS, Solovyeva VV, et al Metachromatic Leukodystrophy: Diagnosis, Modeling, and Treatment Approaches. Front Med (Lausanne). 2020;7:576221. doi:10.3389/fmed.2020.576221. PMID: 33195324.
Kwon JM, Matern D, Kurtzberg J, et al. Consensus guidelines for newborn screening, diagnosis and treatment of infantile Krabbe disease. Orphanet J Rare Dis. 2018;13(1):30. doi:10.1186/s13023-018-0766-x. PMID: 29391017.
Bradbury AM, Bongarzone ER, Sands MS. Krabbe disease: New hope for an old disease. Neurosci Lett. 2021;752:135841. doi:10.1016/j.neulet.2021.135841. PMID: 33766733.
Turk BR, Theda C, Fatemi A, et al. X-linked adrenoleukodystrophy: Pathology, pathophysiology, diagnostic testing, newborn screening and therapies. Int J Dev Neurosci. 2020;80(1):52-72. doi:10.1002/jdn.10003. PMID: 31909500.
Yahia A, Elsayed L, Babai A, et al. Intra-familial phenotypic heterogeneity in a Sudanese family with DARS2-related leukoencephalopathy, brainstem and spinal cord involvement and lactate elevation: a case report. BMC Neurol. 2018;18(1):175. doi:10.1186/s12883-018-1180-7. PMID: 30352563.
Scheper GC, Proud CG, van der Knaap MS. Defective translation initiation causes vanishing of cerebral white matter. Trends Mol Med. 2006;12(4):159-66. doi:10.1016/j.molmed.2006.02.006. PMID: 16545608.
van Kollenburg B, van Dijk J, Garbern J, et al. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease. J Neuropathol Exp Neurol. 2006;65(7):707-15. doi:10.1097/01.jnen.0000228201.27539.50. PMID: 16825957.
Kuhn J, Cascella M. Alexander Disease. 2022 Sep 5. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 32965913.
Bokhari MR, Samanta D, Bokhari SRA. Canavan Disease. 2022 Sep 6. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 28613566.
Blattner R, Von Moers A, Leegwater PA, et al. Clinical and genetic heterogeneity in megalencephalic leukoencephalopathy with subcortical cysts (MLC). Neuropediatrics. 2003;34(4):215-8. doi:10.1055/s-2003-42210. PMID: 12973664.
Raininko R, Gosky M, Padiath QS. LMNB1-Related Autosomal Dominant Leukodystrophy. 2016 Jan 7 [updated 2021 Jul 15]. In: Adam MP, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2023. PMID: 26749591.
Stabile C, Taglia I, Battisti C, et al. Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): update on molecular genetics. Neurol Sci. 2016;37(9):1565-9. doi:10.1007/s10072-016-2634-6. PMID: 27338940.
Van der Knaap MS, Schiffmann R, Mochel F, et al. Diagnosis, prognosis, and treatment of leukodystrophies. Lancet Neurol. 2019;18(10):962-972. doi:10.1016/S1474-4422(19)30143-7. PMID: 31307818.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Wiktoria Sielwanowska, Bartłomiej Syzdoł, Anna Rzewuska, Monika Żybowska, Magdalena Chrościńska-Krawczyk
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 308
Number of citations: 0